What we already know about the Post-COVID-19 Syndrome: A narrative review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/34143 |
Resumo: | As an increasingly number of patients recover from the acute COVID-19 disease, it has been observed that many face long lasting symptoms, referred as the Post-COVID-19 Syndrome. This article covers the most common signs and symptoms of this syndrome, its general aspects, and important complementary exams related to the disease. The manuscript is a narrative review, gathering new evidence published about the topic. The most common symptoms of the Post-COVID-19 Syndrome are chronic fatigue, breathlessness, depression or anxiety, pain, cough and alopecia, and many of them are still present 6 months after hospital discharge from the acute disease, depending on the gravity of the illness. It is important for patients to maintain medical follow-up to access severity of the symptoms and choose whether further investigation is necessary. There are some treatments available to some minimize the long-lasting burden of the syndrome, and the physician should access the need for treatment with the patient. As a new disease, there is a lot of new evidence being produced rapidly, but no up-to-date protocol has already been published. Even with the vaccinations campaigns, the burden of the pandemic is yet out of sight, as it still killing thousands daily, and those who have recovered from the acute COVID-19 illness can present chronic symptoms. Therefore, we recommend health professionals to continuously up-to-date themselves, as new information is added to make better clinical decisions. |
id |
UNIFEI_74f79351b9b13d7101584193116c4217 |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/34143 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
What we already know about the Post-COVID-19 Syndrome: A narrative reviewLo que ya sabemos sobre el Síndrome Post-COVID-19: Una revisión narrativaO que já sabemos sobre a Síndrome Pós-COVID-19: Uma revisão narrativaCOVID-19SARS-CoV-2CoughFatigueChronic disease.COVID-19SARS-CoV-2TosFatigaEnfermedad crónica.COVID-19SARS-CoV-2TosseFatigaDoença crônica.As an increasingly number of patients recover from the acute COVID-19 disease, it has been observed that many face long lasting symptoms, referred as the Post-COVID-19 Syndrome. This article covers the most common signs and symptoms of this syndrome, its general aspects, and important complementary exams related to the disease. The manuscript is a narrative review, gathering new evidence published about the topic. The most common symptoms of the Post-COVID-19 Syndrome are chronic fatigue, breathlessness, depression or anxiety, pain, cough and alopecia, and many of them are still present 6 months after hospital discharge from the acute disease, depending on the gravity of the illness. It is important for patients to maintain medical follow-up to access severity of the symptoms and choose whether further investigation is necessary. There are some treatments available to some minimize the long-lasting burden of the syndrome, and the physician should access the need for treatment with the patient. As a new disease, there is a lot of new evidence being produced rapidly, but no up-to-date protocol has already been published. Even with the vaccinations campaigns, the burden of the pandemic is yet out of sight, as it still killing thousands daily, and those who have recovered from the acute COVID-19 illness can present chronic symptoms. Therefore, we recommend health professionals to continuously up-to-date themselves, as new information is added to make better clinical decisions.A medida que aumenta el número de pacientes que se recuperan de la enfermedad aguda por COVID-19, se ha observado que muchos se enfrentan a síntomas duraderos, denominados Síndrome Post-COVID-19. Este artículo abarca los signos y síntomas más comunes de este síndrome, sus aspectos generales y los exámenes complementarios importantes relacionados con la enfermedad. El manuscrito es una revisión narrativa, que recoge las nuevas evidencias publicadas sobre el tema. Los síntomas más comunes del Síndrome Post-COVID-19 son la fatiga crónica, la disnea, la depresión o la ansiedad, el dolor, la tos y la alopecia, y muchos de ellos siguen presentes 6 meses después del alta hospitalaria de la enfermedad aguda, dependiendo de la gravedad de la enfermedad. Es importante que los pacientes mantengan un seguimiento médico para acceder a la gravedad de los síntomas y elegir si es necesario realizar más investigaciones. Hay algunos tratamientos disponibles para minimizar la carga duradera del síndrome, y el médico debe acceder a la necesidad de tratamiento con el paciente. Al tratarse de una enfermedad nueva, se están produciendo muchas pruebas nuevas rápidamente, pero no se ha publicado ningún protocolo actualizado. Incluso con las campañas de vacunación, la carga de la pandemia aún no está a la vista, ya que sigue matando a miles de personas diariamente, y los que se han recuperado de la enfermedad aguda de COVID-19 pueden presentar síntomas crónicos. Por lo tanto, recomendamos a los profesionales de la salud que se actualicen continuamente, a medida que se añade nueva información para tomar mejores decisiones clínicas.Como um número crescente de pacientes que se recuperam da doença aguda COVID-19, tem sido observado que muitos enfrentam sintomas de longa duração, chamados de Síndrome Pós-COVID-19. Este artigo cobre os sinais e sintomas mais comuns desta síndrome, seus aspectos gerais e exames complementares importantes relacionados com a doença. O manuscrito é uma revisão narrativa, reunindo novas evidências publicadas sobre o tema. Os sintomas mais comuns da Síndrome Pós-COVID-19 são fadiga crônica, falta de ar, depressão ou ansiedade, dor, tosse e alopecia, e muitos deles ainda estão presentes 6 meses após a alta hospitalar da doença aguda, dependendo da gravidade da doença. É importante para os pacientes manter um acompanhamento médico para ter acesso à gravidade dos sintomas e escolher se é necessária uma investigação mais aprofundada. Há alguns tratamentos disponíveis para alguns minimizar a carga duradoura da síndrome, e o médico deve ter acesso à necessidade de tratamento com o paciente. Como uma nova doença, há muitas evidências novas sendo produzidas rapidamente, mas nenhum protocolo atualizado já foi publicado. Mesmo com as campanhas de vacinação, o fardo da pandemia ainda está fora de vista, pois ainda mata milhares diariamente, e aqueles que se recuperaram da doença aguda COVID-19 podem apresentar sintomas crônicos. Portanto, recomendamos aos profissionais de saúde que se atualizem continuamente, pois novas informações são acrescentadas para tomar melhores decisões clínicas.Research, Society and Development2022-09-11info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3414310.33448/rsd-v11i12.34143Research, Society and Development; Vol. 11 No. 12; e108111234143Research, Society and Development; Vol. 11 Núm. 12; e108111234143Research, Society and Development; v. 11 n. 12; e1081112341432525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/34143/28973Copyright (c) 2022 Mariana Dias de Resende; Gabriel Dias de Resende; Lucas Nunes Riquieri; Ana Flávia Arantes dos Santos; Alexandre Cesar Alves de Castro; Mariana da Costa Rochahttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessResende, Mariana Dias de Resende, Gabriel Dias de Riquieri, Lucas Nunes Santos, Ana Flávia Arantes dos Castro, Alexandre Cesar Alves de Rocha, Mariana da Costa 2022-09-26T11:56:08Zoai:ojs.pkp.sfu.ca:article/34143Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:49:33.809342Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
What we already know about the Post-COVID-19 Syndrome: A narrative review Lo que ya sabemos sobre el Síndrome Post-COVID-19: Una revisión narrativa O que já sabemos sobre a Síndrome Pós-COVID-19: Uma revisão narrativa |
title |
What we already know about the Post-COVID-19 Syndrome: A narrative review |
spellingShingle |
What we already know about the Post-COVID-19 Syndrome: A narrative review Resende, Mariana Dias de COVID-19 SARS-CoV-2 Cough Fatigue Chronic disease. COVID-19 SARS-CoV-2 Tos Fatiga Enfermedad crónica. COVID-19 SARS-CoV-2 Tosse Fatiga Doença crônica. |
title_short |
What we already know about the Post-COVID-19 Syndrome: A narrative review |
title_full |
What we already know about the Post-COVID-19 Syndrome: A narrative review |
title_fullStr |
What we already know about the Post-COVID-19 Syndrome: A narrative review |
title_full_unstemmed |
What we already know about the Post-COVID-19 Syndrome: A narrative review |
title_sort |
What we already know about the Post-COVID-19 Syndrome: A narrative review |
author |
Resende, Mariana Dias de |
author_facet |
Resende, Mariana Dias de Resende, Gabriel Dias de Riquieri, Lucas Nunes Santos, Ana Flávia Arantes dos Castro, Alexandre Cesar Alves de Rocha, Mariana da Costa |
author_role |
author |
author2 |
Resende, Gabriel Dias de Riquieri, Lucas Nunes Santos, Ana Flávia Arantes dos Castro, Alexandre Cesar Alves de Rocha, Mariana da Costa |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Resende, Mariana Dias de Resende, Gabriel Dias de Riquieri, Lucas Nunes Santos, Ana Flávia Arantes dos Castro, Alexandre Cesar Alves de Rocha, Mariana da Costa |
dc.subject.por.fl_str_mv |
COVID-19 SARS-CoV-2 Cough Fatigue Chronic disease. COVID-19 SARS-CoV-2 Tos Fatiga Enfermedad crónica. COVID-19 SARS-CoV-2 Tosse Fatiga Doença crônica. |
topic |
COVID-19 SARS-CoV-2 Cough Fatigue Chronic disease. COVID-19 SARS-CoV-2 Tos Fatiga Enfermedad crónica. COVID-19 SARS-CoV-2 Tosse Fatiga Doença crônica. |
description |
As an increasingly number of patients recover from the acute COVID-19 disease, it has been observed that many face long lasting symptoms, referred as the Post-COVID-19 Syndrome. This article covers the most common signs and symptoms of this syndrome, its general aspects, and important complementary exams related to the disease. The manuscript is a narrative review, gathering new evidence published about the topic. The most common symptoms of the Post-COVID-19 Syndrome are chronic fatigue, breathlessness, depression or anxiety, pain, cough and alopecia, and many of them are still present 6 months after hospital discharge from the acute disease, depending on the gravity of the illness. It is important for patients to maintain medical follow-up to access severity of the symptoms and choose whether further investigation is necessary. There are some treatments available to some minimize the long-lasting burden of the syndrome, and the physician should access the need for treatment with the patient. As a new disease, there is a lot of new evidence being produced rapidly, but no up-to-date protocol has already been published. Even with the vaccinations campaigns, the burden of the pandemic is yet out of sight, as it still killing thousands daily, and those who have recovered from the acute COVID-19 illness can present chronic symptoms. Therefore, we recommend health professionals to continuously up-to-date themselves, as new information is added to make better clinical decisions. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-09-11 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/34143 10.33448/rsd-v11i12.34143 |
url |
https://rsdjournal.org/index.php/rsd/article/view/34143 |
identifier_str_mv |
10.33448/rsd-v11i12.34143 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/34143/28973 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 12; e108111234143 Research, Society and Development; Vol. 11 Núm. 12; e108111234143 Research, Society and Development; v. 11 n. 12; e108111234143 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052797683761152 |